References
- 1
Boja J W, Mitchell W M, Patel A, Kopajtic T A, Carroll F I, Lewin A H, Abraham P,
Kuhar M J.
High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat
brain.
Synapse.
1992;
12
27-36
- 2
Bondolfi G, Eap C B, Bertschy G, Zullino D, Vermeulen A, Baumann P.
The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychiatric
patients.
Pharmacopsychiatry.
2002;
35
50-56
- 3
Gurka P, Bacher R, Kemmler G, Hinterhuber H, Lingg A, Marksteiner J.
Pharmacological treatment strategies of residential primary care providers in dementia
disease.
Pharmacopsychiatry.
2002;
35
144-149
- 4
Hiltunen J, Akerman K K, Kuikka J T, Bergstrom K A, Halldin C, Nikula T, Rasanen P,
Tiihonen J, Vauhkonen M, Karhu J, Kupila J, Lansimies E, Farde L.
Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging
in the human brain with single-photon emission tomography.
Eur J Nucl Med.
1998;
25
19-23
- 5
Kurzthaler I, Hotter A, Miller C, Kemmler G, Halder W, Rhomberg H P, Fleischhacker W.
Risk profile of SSrIs in elderly depressive patients with co-morbid physical illness.
Pharmacopsychiatry.
2001;
34
114-118
- 6
Lawrence R M.
Is the finding of obsessional behaviour relevant to the differental diagnosis of Vascular
Dementia of the Binswanger Type?.
Behav Neurol.
2000;
12
149-154
- 7
Mega M S, Cummings J L, Fiorello T, Gornbein J.
The spectrum of behavioral changes in Alzheimer's disease.
Neurology.
1996;
46
130-135
- 8
Meltzer C C, Smith G, DeKosky S T, Pollock B G, Mathis C A, Moore R Y, Kupfer D J,
Reynolds C F.
III. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging
role of functional imaging.
Neuropsychopharmacology.
1998;
18
407-430
- 9
Mintzer J E.
Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
J Clin Psychiat.
2001;
62 Suppl 21
23-25
- 10
Montgomery S A.
Long-term management of obsessive-compulsive disorder.
Int Clin Psychopharmacol.
1996;
11 Suppl 5
23-29
- 11
Raskind M A.
Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
J Clin Psychiat.
1998;
59 Suppl 9
28-32
- 12
Riedel-Heller S G, Matschinger H, Schork A, Angermeyer M C.
The utilization of antidepressants in community-dwelling and institutionalized elderly-results
form a representative survey in Germany.
Pharmacopsychiatry.
2001;
34
6-12
- 13
Sweet R A, Pollock B G, Sukonick D L, Mulsant B H, Rosen J, Klunk W E, Kastango K B,
DeKosky S T, Ferrell R E.
The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and
aggressive behavior in Alzheimer disease.
Int Psychogeriatr .
2001;
13
401-409
- 14
Tauscher J, Pirker W, de Zwaan M, Asenbaum S, Brucke T, Kasper S.
In vivo visualization of serotonin transporters in the human brain during fluoxetine
treatment.
Eur Neuropsychopharmacol.
1999;
9
177-179
- 15
Tauscher J, Pirker W, Willeit M, de Zwaan M, Bailer U, Neumeister A, Asenbaum S, Lennkh C,
Praschak-Rieder N, Brucke T, Kasper S.
[123I] beta-CIT and single photon emission computed tomography reveal reduced brain
serotonin transporter availability in bulimia nervosa.
Biol Psychiat.
2001;
49
326-332
- 16
Troisi A, Vicario E, Nuccetelli F, Ciani N, Pasini A.
Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation
and epilepsy.
Pharmacopsychiatry.
1995;
28
73-76
- 17
Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, Tauscher J,
Hilger E, Stastny J, Brucke T, Kasper S.
[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability
in drug-free depressed patients with seasonal affective disorder.
Biol Psychiat.
2000;
47
482-489
Dr. Josef Marksteiner
Department of Psychiatry
Anichstrasse 35
A-6020 Innsbruck, Austria
Phone: +43 (512) 504-3712
Fax: +43 (512) 504-3628
Email: j.marksteiner@uibk.ac.at
